|
|
|
|
Meet our sponsors...
|
QIAGEN
|
|
QIAGEN aquired DxS, a personalized healthcare company in September 2009 to create a Center of Excellence in Companion Diagnostics. QIAGEN work with pharmaceutical companies to support development of targeted cancer therapies by providing biomarkers and companion diagnostics.
Working primarily in oncology, their product portfolio includes real-time PCR assays for K-RAS, EGFR, B-RAF and PI3K genes, to aid doctors and drug companies select therapies for patients.
QIAGEN is active in more than 15 partnerships with pharmaceutical and large biotech companies in the field of personalized healthcare, including Astra Zeneca, Merck, Amgen, Bristol-Myers Squibb/ImClone Systems, Boehringer-Ingelheim and Pfizer.
|
 |
|
SILICON BIOSYSTEMS
|
|
Silicon Biosystems has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems exploits the microelectronics potential in order to produce miniaturized cellular biology laboratories. The approach patented by Silicon Biosystems has given rise to an unprecedented technology platform able to perform complex protocols, since it offers the unique possibility of controlling individual cells and micro-particles inside a micro-chamber. Silicon Biosystems technology individually manages more than 100,000 cells on a single microelectronic chip, using software control and incorporating sensors to detect the results of complex procedures. The company has a reputation for being one of the most innovative start-ups in the field of “lab-on-a-chip” based on active substrates, as testified by a number of awards and recognitions. Silicon Biosystems is also an industrial member of the nano2Life EC Network of Excellence on nanobiotechnologies.
|
 |
|
|
|
|
Conference:
Day 1
September 21, 8:30am - 5:30pm
Day 2
September 22, 8:30am - 5:30pm
Day 3
September 23, 9am - 5:30pm
|
|
|
|
|
|
|
|
|
